NEW YORK, Feb. 26 QED International Associates, Inc,administrator for the HealthShares(TM) Indexes, a series of 20 underlyingindexes for the HealthShares(TM) Exchange-Traded Funds, today announced thateffective at the opening of trading on Friday February 29, 2008, UCB SA(Brussels: UCB.BR) will replace Axcan Pharma, Inc. (Nasdaq (GS): AXCA) in theHealthShares(TM) GI/Gender Health Index. Axcan Pharma is being acquired by anaffiliate of TPG Capital, a leading private investment firm founded in 1992.
Companies included in the GI/Gender Health Index are engaged in theresearch, clinical development and/or commercialization of therapeutic agentsfor the treatment of a wide variety of diseases including, but not limited to,gastrointestinal disorders such as gastroesophageal reflux disease, heartburn,irritable bowel syndrome, Crohn's Disease and ulcerative colitis;genitourinary disorders such as overactive bladder, urge incontinence, stressincontinence and urinary tract infection; and gender health matters includingsexual dysfunction (male and female), endometriosis, benign prostatichyperplasia, prolapsed womb and reproductive health..
About QED International Associates
QED International Associates, based in New York, is a leading financialindustry consulting firm specializing in quantitative modeling and the design,development and maintenance of indexes and Exchange Traded Funds. For moreinformation, visit the company's website at www.qedinternational.com
SOURCE QED International Associates